NORTRIPTYLINE HYDROCHLORIDE | A074132 | TEVA PHARMACEUTICALS USA INC
Highest NADAC/Unit
$0.2573
per ea
Lowest NADAC/Unit
$0.1111
per ea
Brand NDCs
0
Generic NDCs
9
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00093081301NORTRIPTYLINE HCL 75 MG CAP | $0.2573 | EA | Generic | — | 2026-08-19 |
| 00093081201NORTRIPTYLINE HCL 50 MG CAP | $0.2022 | EA | Generic | — | 2026-08-19 |
| 00093081205NORTRIPTYLINE HCL 50 MG CAP | $0.2022 | EA | Generic | — | 2026-08-19 |
| 00093081105NORTRIPTYLINE HCL 25 MG CAP | $0.1516 | EA | Generic | — | 2026-08-19 |
| 60687091101NORTRIPTYLINE HCL 25 MG CAP | $0.1516 | EA | Generic | — | 2026-08-19 |
| 00093081101NORTRIPTYLINE HCL 25 MG CAP | $0.1516 | EA | Generic | — | 2026-08-19 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.